Crossmark

Short-course radiotherapy with or without temozolomide in elderly patients with newly diagnosed glioblastoma: a time-to-event meta-analysis of overall and progression-free survival

Crossref DOI link: https://doi.org/10.1007/s11060-025-05352-y

Published Online: 2025-11-27

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Darko, Kwadwo

Chen, Jianan

Eckel-Passow, Jeanette E.

Fonkem, Ekokobe

Geyer, Susan

Etame, Arnold B.
License Information

Text and Data Mining valid from 2025-11-27

Version of Record valid from 2025-11-27
More Information

Article History

Received: 31 October 2025

Accepted: 24 November 2025

First Online: 27 November 2025

Declarations

:

: This study was written in compliance with our institutional ethical review board. IRB approval was not required given the nature of the data collected and information presented.

: N/A.

: N/A.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below